Our People

Contact Information

patvlkm@nus.edu.sg

Telephone

+65 6772 4381

Research Themes

BONE & SOFT TISSUE CANCER
WNT SIGNALLING
AI PATHOLOGY

Other Information

ORCID

orcid.org/0000-0001-7803-0005

Victor Lee Kwan Min

ASSOCIATE PROFESSOR, NUS
SENIOR CONSULTANT, NUH
PRINCIPAL INVESTIGATOR, NUS

RESEARCH FOCUS

Investigating the molecular mechanism driving oncogenesis in osteosarcoma and soft tissue sarcoma
Investigating how targeting components of Wnt signaling pathway may impede oncogenesis process in bone and soft tissue sarcoma

BIOGRAPHY

A/Prof Victor Lee Kwan Min is a Senior Consultant Pathologist in NCIS and Department of Pathology, NUH. He graduated from the University of Melbourne in 1994 and underwent his post-graduate pathology training in Royal Prince Alfred Hospital, Canberra Hospital and Monash Medical Centre in Australia. He was awarded Fellowship of the Royal College of Pathologists of Australasia in 2003. A/Prof Lee was also the Program Director of the NUHS Pathology Group between the period of 2009 – 2013 and is currently the Clinical Director and Deputy HoD for Department of Pathology NUS.

Group Members

ARTHUR SIM YI LOONG
NAW WAH WAH
LEONG SAI MUN
CHERRY WEE
KENON CHUA (DUKE NUS)

Recent Publications

EHMT2 epigenetically suppresses Wnt signaling and is a potential target in embryonal rhabdomyosarcoma. Pal A, et al. Elife. 2020. 30;9:e57683.

YJ5 as an immunohistochemical marker of osteogenic lineage. Chua K, et al. Pathology. 2020. 10:S0031-3025(20)30942-9.

A rare case of congenital spindle cell rhabdomyosarcoma with TEAD1-NCOA2 fusion: A subset of spindle cell rhabdomyosarcoma with indolent behavior. Tan GZL, et al. Pathol Int. 2020.70(4):234-236.

Cutaneous "fibroma-like" perivascular epithelioid cell tumor: A case report and review of literature. Odoño EIG, et al. J Cutan Pathol. 2020 Jun;47(6):548-553.

Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma. Bhat AV, et al. Cancer Res. 2019 May 1;79(9):2232-2243.

Spindle cell tumour with S100 and CD34 co-expression showing PDZRN3-RAF1 rearrangement - a recently described entity. Mok Y, et al. Histopathology. 2019 Jun;74(7):1109-1111.